A growing trend among Generation Z is opting for cannabis over alcohol, with many embracing a “California Sober” lifestyle. However, a recent study has cast doubt on the effectiveness of cannabis in treating mental health disorders and substance-use disorders.
Researchers from the University of Sydney analyzed 54 randomized controlled trials on the use of cannabinoids as a primary treatment for mental health conditions. The study, published in The Lancet Psychiatry, found that depression, anxiety, and PTSD are common reasons for cannabis prescription in the US, UK, and Australia. However, the researchers concluded that there is no strong evidence to support the use of cannabis in treating these conditions.
The study also found that the risk of adverse side effects was significantly higher, with a 75% increased risk compared to other treatments. The analysis ultimately concluded that the routine use of cannabinoid treatments for mental health disorders is rarely justified.
Despite the lack of conclusive evidence, the “California Sober” trend continues to gain popularity, with many young adults opting for cannabis over traditional intoxicants. As the debate surrounding cannabis and mental health continues, it is clear that more research is needed to fully understand the effects of cannabis on mental health.
